Tactics of treatment of acute gastroduodenal ulcerative bleeding in patients with ischemic heart disease

Objectives. To evaluate the results of treatment of acute gastroduodenal ulcerative bleeding in patients with ischemic heart disease. Materials and methods. A retrospective study of 174 patients with ischemic heart disease who were hospitalized with acute gastroduodenal ulcerative bleeding in the period from 2016 to 2024 was conducted. There were 112 men (64.4%) and 62 women (35.6%) among the patients. The average age of the patients was 68.4±8.7 years. Results. The efficiency of primary endoscopic hemostasis was 80.5%. In 19.5% of cases, alternative methods were required. Transcatheter arterial embolization was performed in 14.9% of patients, with technical success in 92.3% of cases. Surgical intervention was necessary in 4.6% of patients who experienced a recurrence of bleeding after the ineffectiveness of endoscopic and endovascular methods. Conclusion. The most reliable and safe method of hemostasis in patients with ischemic heart disease is the endovascular method, which is characterized by the lowest frequency of bleeding recurrence (7.7%). The combination of ischemic heart disease and acute gastroduodenal ulcerative bleeding causes diagnostic difficulties, which requires a multidisciplinary approach from both a surgeon and a cardiologist to determine the priority treatment.